DASATINIB Side Effects

7019832-9 | Haemodialysis, Pneumonia, Renal Failure Acute, Sepsis, Tumour Lysis Syndrome, Uraemic Encephalopathy
on Sep 24, 2010 Male patient from TURKEY , 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: haemodialysis, pneumonia (What is pneumonia?), renal failure acute, sepsis (What is sepsis?), tumour lysis syndrome, uraemic encephalopathy. Dasatinib dosage: Discontinued And Resumed At A Dose Of 1 Times 50mg. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

7015627-0 | Decreased Appetite, Dehydration, Dyspnoea, Fatigue, Ocular Hyperaemia
Patient was taking Dasatinib (View Usage). Patient had the following side effects: decreased appetite, dehydration, dyspnoea, fatigue, ocular hyperaemia on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 202.8 lb, was diagnosed with non-small cell lung cancer and. Dasatinib dosage: . During the same period patient was treated with FLOMAX (View Flomax Review and Flomax Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ALBUTEROL (1 Df:2 Puffs) (View Albuterol Review and Albuterol Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

7009271-9 | Angina Pectoris, Asthenia, Chronic Obstructive Pulmonary Disease, Dyspnoea, Loss Of Consciousness, Pneumonia, Productive Cough
Adverse event was reported on Sep 17, 2010 by a Female patient taking Dasatinib (View Usage) (Dosage: Interrupted On 7jul10) was diagnosed with breast cancer (What is breast cancer?), mineral supplementation, vitamin supplementation, nausea (What is nausea?), pain (What is pain?), pyrexia, parkinson's disease (What is parkinson's disease?) and. Location: UNITED STATES , 73 years of age, weighting 251.3 lb, After Dasatinib was administered, patient had the following side effects: angina pectoris, asthenia, chronic obstructive pulmonary disease, dyspnoea, loss of consciousness, pneumonia (What is pneumonia?), productive cough. During the same period patient was treated with FULVESTRANT (Interrupted On 7jul10) (View Fulvestrant Review and Fulvestrant Label ), OSCAL D (View Oscal D Review and Oscal D Label ), VITAMIN D (1df=50000 Units) (View Vitamin D Review and Vitamin D Label ), MULTI VITAMIN (1df:1tab) (View Multi-vitamin Review and Multi-vitamin Label ), COMPAZINE (Q6h) (View Compazine Review and Compazine Label ), TYLENOL (Q46h) (View Tylenol Review and Tylenol Label ), CARBIDOPA (1df:25:100 Mg) (View Carbidopa Review and Carbidopa Label ).

7005290-7 | Haemoglobin Decreased
on Sep 20, 2010 Male patient from UNITED STATES , 55 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased. Dasatinib dosage: 100 Mg Po. During the same period patient was treated with OXYCODONE (View Oxycodone Review and Oxycodone Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MORPHINE (View Morphine Review and Morphine Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), LASIX (View Lasix Review and Lasix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ).


6993005-8 | Hallucination, Malignant Neoplasm Progression, Nausea
on Sep 10, 2010 Female patient from UNITED KINGDOM , 82 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib (View Usage). Patient had the following side effects: hallucination, malignant neoplasm progression, nausea (What is nausea?). Dasatinib dosage: 1 Df = 50-100 Mg Duration:1 1/2 Months.

6993001-0 |
Patient was taking Dasatinib (View Usage). on Sep 10, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 57 years of age, was diagnosed with chronic myeloid leukaemia and. Dasatinib dosage: Duration:0.75months.

6992992-1 | Blood Glucose Increased, Dyspnoea, Haemoglobin Decreased, Lymphopenia, Myocarditis, Pleural Effusion
Adverse event was reported on Sep 10, 2010 by a Female patient taking Dasatinib (View Usage) (Dosage: ) was diagnosed with ovarian epithelial cancer and. Location: UNITED STATES , 78 years of age, weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, dyspnoea, haemoglobin decreased, lymphopenia, myocarditis, pleural effusion. Patient was hospitalized.

6992236-0 | Angina Pectoris, Asthenia, Chronic Obstructive Pulmonary Disease, Dyspnoea, Loss Of Consciousness, Pneumonia, Productive Cough
on Sep 10, 2010 Female patient from UNITED STATES , 73 years of age, weighting 251.3 lb, was diagnosed with breast cancer (What is breast cancer?), mineral supplementation, vitamin supplementation, nausea (What is nausea?), pain (What is pain?), pyrexia, parkinson's disease (What is parkinson's disease?) and was treated with Dasatinib (View Usage). Patient had the following side effects: angina pectoris, asthenia, chronic obstructive pulmonary disease, dyspnoea, loss of consciousness, pneumonia (What is pneumonia?), productive cough. Dasatinib dosage: Interrupted On 7jul10. During the same period patient was treated with FULVESTRANT (Interrupted On 7jul10) (View Fulvestrant Review and Fulvestrant Label ), OSCAL D (View Oscal D Review and Oscal D Label ), VITAMIN D (1df=50000 Units) (View Vitamin D Review and Vitamin D Label ), MULTI VITAMIN (1df:1tab) (View Multi-vitamin Review and Multi-vitamin Label ), COMPAZINE (Q6h) (View Compazine Review and Compazine Label ), TYLENOL (Q46h) (View Tylenol Review and Tylenol Label ), CARBIDOPA (1df:25:100 Mg) (View Carbidopa Review and Carbidopa Label ).

6992205-0 | Anaemia, Myelodysplastic Syndrome, Neutropenia, Thrombocytopenia
on Sep 10, 2010 Male patient from UNITED KINGDOM , 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: anaemia, myelodysplastic syndrome, neutropenia, thrombocytopenia. Dasatinib dosage: 1df=70-100 Mg.

6984908-9 | Acute Pulmonary Oedema, Atrial Fibrillation, Gastric Ulcer, Hypertension, Shock, Upper Gastrointestinal Haemorrhage
Patient was taking Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, atrial fibrillation (What is atrial fibrillation?), gastric ulcer, hypertension, shock, upper gastrointestinal haemorrhage on Sep 08, 2010 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with acute lymphocytic leukaemia and. Dasatinib dosage: . During the same period patient was treated with LOVENOX (0.7ml X 2) (View Lovenox Review and Lovenox Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ).

6966737-5 | Hypoxia, Mucosal Inflammation
Adverse event was reported on Aug 31, 2010 by a Female patient taking Dasatinib (View Usage) (Dosage: Dosage:on Days1-14 And 29-42) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED STATES , child 12 years of age, weighting 176.4 lb, Patient had the following side effects: hypoxia, mucosal inflammation. During the same period patient was treated with HYDROCORTISONE (Given In Iit) (View Hydrocortisone Review and Hydrocortisone Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (9750 Mg Hd 29jul10 15 Mg Itt On 28jul10) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6966425-5 | Malignant Peritoneal Neoplasm, Pleural Effusion
on Aug 31, 2010 Female patient from ARGENTINA , 70 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: malignant peritoneal neoplasm, pleural effusion. Dasatinib dosage: Interrupted In April 2010.

6937762-5 | Febrile Neutropenia, Malignant Neoplasm Progression, Presyncope, Rectal Haemorrhage
on Aug 19, 2010 Female patient from BRAZIL , 13 years of age, was diagnosed with leukaemia and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, malignant neoplasm progression, presyncope, rectal haemorrhage. Dasatinib dosage: . During the same period patient was treated with CLAVULANATE POTASSIUM (View Clavulanate Potassium Review and Clavulanate Potassium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6932592-2 | Acute Myeloid Leukaemia, Cytogenetic Abnormality, Fungal Sepsis
Patient was taking Dasatinib (View Usage). Patient had the following side effects: acute myeloid leukaemia, cytogenetic abnormality, fungal sepsis on Aug 18, 2010 from SWEDEN Additional patient health information: Female patient , 55 years of age, was diagnosed with chronic myeloid leukaemia and. Dasatinib dosage: Initiated In February. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), IMATINIB MESYLATE (Increased Upto 800 Mg/day) (View Imatinib Mesylate Review and Imatinib Mesylate Label ).

6930799-1 | Sepsis
Adverse event was reported on Aug 13, 2010 by a Male patient taking Dasatinib (View Usage) (Dosage: Interrupted 05jun2010) was diagnosed with acute myeloid leukaemia and. Location: GERMANY , 48 years of age, weighting 194.0 lb, After Dasatinib was administered, patient had the following side effects: sepsis (What is sepsis?). During the same period patient was treated with CYTARABINE (1 Df=12000 Units Not Specified. Interrupted 23may10) (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ), AMPICILLIN AND SULBACTAM (View Ampicillin And Sulbactam Review and Ampicillin And Sulbactam Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ). Patient was hospitalized and became disabled.

6928003-3 | Acute Myeloid Leukaemia, Cytogenetic Abnormality, Fungal Sepsis
on Aug 11, 2010 Female patient from SWEDEN , 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, cytogenetic abnormality, fungal sepsis. Dasatinib dosage: Initiated In February. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), IMATINIB MESYLATE (View Imatinib Mesylate Review and Imatinib Mesylate Label ).

6926025-X | Febrile Neutropenia, Malignant Neoplasm Progression, Presyncope, Rectal Haemorrhage
on Aug 11, 2010 Female patient from BRAZIL , 13 years of age, was diagnosed with leukaemia and was treated with Dasatinib (View Usage). Patient had the following side effects: febrile neutropenia, malignant neoplasm progression, presyncope, rectal haemorrhage. Dasatinib dosage: . During the same period patient was treated with CLAVULANATE POTASSIUM (View Clavulanate Potassium Review and Clavulanate Potassium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6920616-8 | Febrile Neutropenia, Malignant Neoplasm Progression, Presyncope, Rectal Haemorrhage
Patient was taking Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: febrile neutropenia, malignant neoplasm progression, presyncope, rectal haemorrhage on Aug 06, 2010 from BRAZIL Additional patient health information: Female patient , 13 years of age, was diagnosed with leukaemia and. Dasatinib dosage: . During the same period patient was treated with CLAVULANATE POTASSIUM (View Clavulanate Potassium Review and Clavulanate Potassium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6920614-4 | Pyrexia, Sepsis
Adverse event was reported on Aug 09, 2010 by a Male patient taking Dasatinib (View Usage) (Dosage: Interrupted 05jun2010) was diagnosed with acute myeloid leukaemia and. Location: GERMANY , 48 years of age, weighting 194.0 lb, Patient experienced the following unwanted or unexpected effects: pyrexia, sepsis (What is sepsis?). During the same period patient was treated with CYTARABINE (1 Df=12000 Units Not Specified. Interrupted 23may10) (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ), AMPICILLIN AND SULBACTAM (View Ampicillin And Sulbactam Review and Ampicillin And Sulbactam Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ). Patient was hospitalized and became disabled.

6916509-2 | Malignant Neoplasm Progression, Presyncope, Rectal Haemorrhage
on Aug 03, 2010 Female patient from BRAZIL , 13 years of age, was diagnosed with leukaemia and was treated with Dasatinib (View Usage). Patient had the following side effects: malignant neoplasm progression, presyncope, rectal haemorrhage. Dasatinib dosage: . During the same period patient was treated with CLAVULANATE POTASSIUM (View Clavulanate Potassium Review and Clavulanate Potassium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6899922-1 | Pyrexia, Sepsis
on Jul 28, 2010 Male patient from GERMANY , 48 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: pyrexia, sepsis (What is sepsis?). Dasatinib dosage: Interrupted 05-jun-2010. During the same period patient was treated with CYTARABINE (1 Df-1200 Units Not Specified. Interrupted 23may10) (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ), AMPICILLIN AND SULBACTAM (View Ampicillin And Sulbactam Review and Ampicillin And Sulbactam Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ). Patient was hospitalized and became disabled.

6895490-9 | Dyspnoea, Pleural Effusion, Respiratory Failure
Patient was taking Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, pleural effusion, respiratory failure on Jul 26, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 119.0 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension, nausea (What is nausea?), vitamin supplementation, night sweats, headache (What is headache?) and. Dasatinib dosage: 50mg; Lot No:9b51205,exp.date:31mar2012 09jun To 08jul2010. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), ZOFRAN (View Zofran Review and Zofran Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), ALEVE (CAPLET) (Prn) (View Aleve (caplet) Review and Aleve (caplet) Label ), ACETAMINOPHEN (1 Df=500mg 1 To 2 Tabs) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6894768-2 | Pericardial Effusion, Pleural Effusion
Adverse event was reported on Jul 30, 2010 by a Male patient taking Dasatinib (View Usage) (Dosage: 100mg Daily Po) was diagnosed with lung neoplasm malignant and. Location: UNITED STATES , weighting 179.0 lb, Patient had the following side effects: pericardial effusion, pleural effusion. Patient was hospitalized.

6888310-X | Affect Lability, Anxiety, Depression, Fatigue, Suicidal Ideation, Therapeutic Response Decreased
on Jul 23, 2010 Male patient from BRAZIL , 58 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: affect lability, anxiety (What is anxiety?), depression (What is depression?), fatigue, suicidal ideation, therapeutic response decreased. Dasatinib dosage: .

6880181-0 | Malignant Neoplasm Progression
on Apr 09, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression. Dasatinib dosage: .

6880155-X | Failure To Thrive, Nausea
Patient was taking Dasatinib (View Usage). Patient had the following side effects: failure to thrive, nausea (What is nausea?) on Feb 24, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, . Dasatinib dosage: . Patient was hospitalized.

6880152-4 | Rash
Adverse event was reported on Feb 18, 2010 by a Female patient taking Dasatinib (View Usage) (Dosage: ) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED STATES , 76 years of age, After Dasatinib was administered, patient had the following side effects: rash (What is rash?).

6880137-8 | Malignant Neoplasm Progression, Pneumonia
on Jan 12, 2010 Male patient from UNITED STATES , 41 years of age, weighting 154.3 lb, was diagnosed with malignant neoplasm of pleura, metastatic neoplasm and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression, pneumonia (What is pneumonia?). Dasatinib dosage: Batch Nos 5m042442/348033, 5m04242/35/653. During the same period patient was treated with MORPHINE (Also Received 15 Mg Every 12 Hours Also Given Iv Drip) (View Morphine Review and Morphine Label ), MEGACE (View Megace Review and Megace Label ), CELEXA (View Celexa Review and Celexa Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

6880107-X | Electrocardiogram Qt Prolonged, Pleural Effusion, Supraventricular Tachycardia
on Oct 16, 2009 Female patient from UNITED STATES , 64 years of age, weighting 149.9 lb, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with Dasatinib (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, pleural effusion, supraventricular tachycardia. Dasatinib dosage: Dosage Reduced To 50mg Oral Twice Daily. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ATIVAN (View Ativan Review and Ativan Label ), CARDIZEM CD (View Cardizem Cd Review and Cardizem Cd Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), PAXIL (View Paxil Review and Paxil Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6880105-6 | Abdominal Pain, Asthenia, Hyperhidrosis, Pyrexia, Renal Failure
Patient was taking Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, hyperhidrosis, pyrexia, renal failure on Oct 14, 2009 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with chronic myeloid leukaemia, hypothyroidism, renal failure and. Dasatinib dosage: . During the same period patient was treated with SYNTHROID (Tabs Unk Dose As High As 260mcg (1989 To 1993 - Unk)) (View Synthroid Review and Synthroid Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ESCITALOPRAM OXALATE (Tabs) (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), METOPROLOL SUCCINATE (Tabs) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SEVELAMER HCL (Tabs 800mg, 1 In 8 Hr) (View Sevelamer Hcl Review and Sevelamer Hcl Label ). Patient was hospitalized.

6880100-7 | Gingival Pain, Toothache
Adverse event was reported on Sep 16, 2009 by a Female patient taking Dasatinib (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: gingival pain, toothache. During the same period patient was treated with COMBIGAN (Form=solution) (View Combigan Review and Combigan Label ), CLARITIN (View Claritin Review and Claritin Label ), MOTRIN (View Motrin Review and Motrin Label ), XANAX (View Xanax Review and Xanax Label ), AMBIEN (View Ambien Review and Ambien Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6880068-3 | Pregnancy
on Jun 11, 2009 Female patient from UNITED STATES , 21 years of age, was treated with Dasatinib (View Usage). Patient had the following side effects: pregnancy (What is pregnancy?). Dasatinib dosage: .

6870935-9 | Malignant Neoplasm Progression, Rectal Haemorrhage
on Jul 21, 2010 Female patient from BRAZIL , 13 years of age, was diagnosed with leukaemia and was treated with Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: malignant neoplasm progression, rectal haemorrhage. Dasatinib dosage: . During the same period patient was treated with CLAVULANATE POTASSIUM (View Clavulanate Potassium Review and Clavulanate Potassium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6868966-8 | Dyspnoea, Unevaluable Event
Patient was taking Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, unevaluable event on Jul 22, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 104.7 lb, was diagnosed with non-small cell lung cancer and. Dasatinib dosage: Dasatinib 70mg Bid Po.

6816501-2 | Lower Gastrointestinal Haemorrhage
Adverse event was reported on Jun 29, 2010 by a Female patient taking Dasatinib (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?), pain (What is pain?), pyrexia, abdominal pain (What is abdominal pain?) and. Location: UNITED STATES , 42 years of age, Patient had the following side effects: lower gastrointestinal haemorrhage. During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), ADVIL LIQUI GELS (View Advil Liqui-gels Review and Advil Liqui-gels Label ), ADVIL LIQUI GELS (View Advil Liqui-gels Review and Advil Liqui-gels Label ), BENTYL (View Bentyl Review and Bentyl Label ), CALCIUM + VITAMIN D (View Calcium + Vitamin D Review and Calcium + Vitamin D Label ).

6814400-3 | Cardiomyopathy, Graft Versus Host Disease, Malignant Neoplasm Progression
on Jun 21, 2010 Female patient from UNITED STATES , 27 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), graft versus host disease, malignant neoplasm progression. Dasatinib dosage: . During the same period patient was treated with IMATINIB MESYLATE (View Imatinib Mesylate Review and Imatinib Mesylate Label ), NILOTINIB (View Nilotinib Review and Nilotinib Label ). Patient was hospitalized.

6814396-4 | Subdural Haematoma
on Jun 28, 2010 Male patient from NETHERLANDS , 70 years of age, was diagnosed with glioblastoma and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: subdural haematoma. Dasatinib dosage: 1 Df= 100(unit Not Spec). Interupted On 10jun10, Oral. During the same period patient was treated with CCNU (1 Df= 220(unit Not Spec)) (View Ccnu Review and Ccnu Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ). Patient was hospitalized.

6812910-6 | Fluid Overload, Gastritis, Herpes Simplex, Neurotoxicity, Pericardial Haemorrhage, Pneumonia, Renal Impairment, Respiratory Distress, Tremor
Patient was taking Dasatinib (View Usage). Patient had the following side effects: fluid overload, gastritis, herpes simplex (What is herpes simplex?), neurotoxicity, pericardial haemorrhage, pneumonia (What is pneumonia?), renal impairment, respiratory distress, tremor on Jun 25, 2010 from UNITED STATES Additional patient health information: Female patient , 13 years of age, weighting 63.93 lb, was diagnosed with bone sarcoma and. Dasatinib dosage: Interrupted 01dec08; Continued At 25 Mg/m2 Bid 12dec To 13dec08,1.5mg,0.5mg,2.0mg,3.5mg Prn.. During the same period patient was treated with IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), TYLENOL (View Tylenol Review and Tylenol Label ), BENADRYL (View Benadryl Review and Benadryl Label ), BACTRIM (F/s/s) (View Bactrim Review and Bactrim Label ), HYDROMORPHONE (Dosage:/hr.) (View Hydromorphone Review and Hydromorphone Label ). Patient was hospitalized.

6774648-3 | Febrile Neutropenia, Sepsis
Adverse event was reported on Jun 14, 2010 by a Male patient taking Dasatinib (View Usage) (Dosage: ) was diagnosed with leukaemia and. Location: UNITED KINGDOM , 27 years of age, After Dasatinib was administered, patient had the following side effects: febrile neutropenia, sepsis (What is sepsis?). During the same period patient was treated with MST (View Mst Review and Mst Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

6770806-2 | Chest Pain, Cholelithiasis, Pancreatitis
on Jun 14, 2010 Male patient from UNITED STATES , weighting 169.8 lb, was diagnosed with prostate cancer metastatic and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), cholelithiasis, pancreatitis. Dasatinib dosage: 100mg Daily Po. During the same period patient was treated with CALCIUM PLUS VITAMIN D (View Calcium Plus Vitamin D Review and Calcium Plus Vitamin D Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), LUPRON (View Lupron Review and Lupron Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), CRESTOR (View Crestor Review and Crestor Label ), ZETIA (View Zetia Review and Zetia Label ), SENOKOT (View Senokot Review and Senokot Label ). Patient was hospitalized.

6770283-1 | Oesophageal Pain, Radiation Oesophagitis
on Jun 10, 2010 Male patient from UNITED STATES , 40 years of age, weighting 125.7 lb, was diagnosed with non-small cell lung cancer and was treated with Dasatinib (View Usage). Patient had the following side effects: oesophageal pain, radiation oesophagitis. Dasatinib dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (1 Df= Auc 2) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6768346-X | Pyrexia
Patient was taking Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: pyrexia on Jun 08, 2010 from GERMANY Additional patient health information: Male patient , 48 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and. Dasatinib dosage: . During the same period patient was treated with CYTARABINE (1 Df-1200 Units Not Specified.) (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ), AMPICILLIN AND SULBACTAM (View Ampicillin And Sulbactam Review and Ampicillin And Sulbactam Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ). Patient was hospitalized.

6767422-5 | Pain, Radiation Oesophagitis
Adverse event was reported on Jun 11, 2010 by a Male patient taking Dasatinib (View Usage) (Dosage: 70 Mg Daily Po) was diagnosed with lung neoplasm malignant and. Location: UNITED STATES , weighting 126.3 lb, Patient experienced the following unwanted or unexpected effects: pain (What is pain?), radiation oesophagitis. During the same period patient was treated with TAXOL (50 Mg/m2 Weekly Iv) (View Taxol Review and Taxol Label ), CARBOPLATIN (Auc 2 Weekly Iv) (View Carboplatin Review and Carboplatin Label ), RADIATION EXTERNAL BEAM (45 Gy) (View Radiation -external Beam Review and Radiation -external Beam Label ). Patient was hospitalized.

6761542-7 | Hypokalaemia
on Jun 04, 2010 Male patient from UNITED STATES , child 6 years of age, weighting 74.96 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Dasatinib (View Usage). Patient had the following side effects: hypokalaemia. Dasatinib dosage: Days 1 - 14 No Of Course:3 Last Inf:17feb10. During the same period patient was treated with ETOPOSIDE (Days 1 - 5) (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (Days 1 - 5) (View Ifosfamide Review and Ifosfamide Label ), HYDROCORTISONE (No Of Course:3 Day 1 Last Dose: 04feb10) (View Hydrocortisone Review and Hydrocortisone Label ), CYTARABINE (Itt 16 - 30 Mg Day 1 Iv 3000 Mg/m2 Days 2 + 3 No Of Course:3 Last Inf:07feb10) (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (5445mg Hdmtx Iv And 12mg Itt Mtx No Of Course:3 Last Inf:4feb10) (View Methotrexate Review and Methotrexate Label ), DEXTROSE + SALINE (View Dextrose + Saline Review and Dextrose + Saline Label ).

6748019-X | Osteonecrosis
on May 26, 2010 Female patient from CHINA , 54 years of age, was diagnosed with leukaemia and was treated with Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). Dasatinib dosage: Interrupted On 06may2010. 140mg:10sep08to03apr09 100mg:22apr09to07dec09 80:15dec09to04may10.

6743314-2 | Bone Marrow Failure, Pneumonia, Septic Shock
Patient was taking Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, pneumonia (What is pneumonia?), septic shock on May 21, 2010 from MEXICO Additional patient health information: Male patient , 58 years of age, was diagnosed with chronic myeloid leukaemia and. Dasatinib dosage: . During the same period patient was treated with ETOPOSIDE (Day 1,2,3) (View Etoposide Review and Etoposide Label ), IDARUBICIN HCL (Day 1,2,3) (View Idarubicin Hcl Review and Idarubicin Hcl Label ), CYTARABINE (Day 1,2,3) (View Cytarabine Review and Cytarabine Label ).

6742352-3 | Hypokalaemia, Hypomagnesaemia, Hypotension, Supraventricular Tachyarrhythmia
Adverse event was reported on May 19, 2010 by a Male patient taking Dasatinib (View Usage) (Dosage: Last Admin:22-apr-2010) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 84 years of age, weighting 187.4 lb, Patient had the following side effects: hypokalaemia, hypomagnesaemia, hypotension, supraventricular tachyarrhythmia. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (1 Df= Auc 2) (View Carboplatin Review and Carboplatin Label ), SPECTRAVITE (View Spectravite Review and Spectravite Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ). Patient was hospitalized.

6740346-5 | Cardiac Failure Congestive, Pleural Effusion
on May 19, 2010 Female patient from UNITED STATES , 73 years of age, was diagnosed with leukaemia and was treated with Dasatinib (View Usage). After Dasatinib was administered, patient had the following side effects: cardiac failure congestive, pleural effusion. Dasatinib dosage: 12jan-21jan06=140(unit Not Specified) 31jan06-22jun09=100 29jul09-unk=80. Patient was hospitalized.

6739847-5 | Hypokalaemia, Hypomagnesaemia, Hypotension, Supraventricular Tachyarrhythmia
on May 19, 2010 Male patient from UNITED STATES , 84 years of age, weighting 187.4 lb, was diagnosed with non-small cell lung cancer and was treated with Dasatinib (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, hypomagnesaemia, hypotension, supraventricular tachyarrhythmia. Dasatinib dosage: Last Admin:22-apr-2010. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (1 Df= Auc 2) (View Carboplatin Review and Carboplatin Label ), SPECTRAVITE (View Spectravite Review and Spectravite Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ). Patient was hospitalized.

6739761-5 | Hypokalaemia
Patient was taking Dasatinib (View Usage). Patient had the following side effects: hypokalaemia on May 14, 2010 from UNITED STATES Additional patient health information: Male patient , child 6 years of age, weighting 74.96 lb, was diagnosed with acute lymphocytic leukaemia and. Dasatinib dosage: Days 1 - 14 No Of Course:3 Last Inf:17feb10. During the same period patient was treated with ETOPOSIDE (Days 1 - 5) (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (Days 1 - 5) (View Ifosfamide Review and Ifosfamide Label ), HYDROCORTISONE (No Of Course:3 Day 1 Last Dose: 04feb10) (View Hydrocortisone Review and Hydrocortisone Label ), CYTARABINE (Itt 16 - 30 Mg Day 1 Iv 3000 Mg/m2 Days 2 + 3 No Of Course:3 Last Inf:07feb10) (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (5445mg Hdmtx Iv And 12mg Itt Mtx No Of Course:3 Last Inf:4feb10) (View Methotrexate Review and Methotrexate Label ), DEXTROSE + SALINE (View Dextrose + Saline Review and Dextrose + Saline Label ).